These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Serum levels of mitochondrial inhibitory factor 1 are independently associated with long-term prognosis in coronary artery disease: the GENES Study. Genoux A; Lichtenstein L; Ferrières J; Duparc T; Bongard V; Vervueren PL; Combes G; Taraszkiewicz D; Elbaz M; Galinier M; Nassar B; Ruidavets JB; Perret B; Martinez LO BMC Med; 2016 Aug; 14(1):125. PubMed ID: 27553421 [TBL] [Abstract][Full Text] [Related]
4. RhoA/ROCK I signalling downstream of the P2Y13 ADP-receptor controls HDL endocytosis in human hepatocytes. Malaval C; Laffargue M; Barbaras R; Rolland C; Peres C; Champagne E; Perret B; Tercé F; Collet X; Martinez LO Cell Signal; 2009 Jan; 21(1):120-7. PubMed ID: 18948190 [TBL] [Abstract][Full Text] [Related]
5. The ectopic F(O)F(1) ATP synthase of rat liver is modulated in acute cholestasis by the inhibitor protein IF1. Giorgio V; Bisetto E; Franca R; Harris DA; Passamonti S; Lippe G J Bioenerg Biomembr; 2010 Apr; 42(2):117-23. PubMed ID: 20180002 [TBL] [Abstract][Full Text] [Related]
6. Serum IF1 concentration is independently associated to HDL levels and to coronary heart disease: the GENES study. Genoux A; Ruidavets JB; Ferrières J; Combes G; Lichtenstein L; Pons V; Laffargue M; Taraszkiewicz D; Carrié D; Elbaz M; Perret B; Martinez LO J Lipid Res; 2013 Sep; 54(9):2550-8. PubMed ID: 23794714 [TBL] [Abstract][Full Text] [Related]
7. Ecto-F1-ATPase/P2Y pathways in metabolic and vascular functions of high density lipoproteins. Martinez LO; Najib S; Perret B; Cabou C; Lichtenstein L Atherosclerosis; 2015 Jan; 238(1):89-100. PubMed ID: 25437896 [TBL] [Abstract][Full Text] [Related]
8. The β-chain of cell surface F(0)F(1) ATPase modulates apoA-I and HDL transcytosis through aortic endothelial cells. Cavelier C; Ohnsorg PM; Rohrer L; von Eckardstein A Arterioscler Thromb Vasc Biol; 2012 Jan; 32(1):131-9. PubMed ID: 21979433 [TBL] [Abstract][Full Text] [Related]
9. ATPase Inhibitory Factor 1-A Novel Marker of Cellular Fitness and Exercise Capacity? Domin R; Pytka M; Niziński J; Żołyński M; Zybek-Kocik A; Wrotkowska E; Zieliński J; Guzik P; Ruchała M Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499630 [TBL] [Abstract][Full Text] [Related]
10. IF(1) distribution in HepG2 cells in relation to ecto-F(0)F (1)ATPsynthase and calmodulin. Contessi S; Comelli M; Cmet S; Lippe G; Mavelli I J Bioenerg Biomembr; 2007 Aug; 39(4):291-300. PubMed ID: 17851741 [TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein A-I enhances proliferation of human endothelial progenitor cells and promotes angiogenesis through the cell surface ATP synthase. González-Pecchi V; Valdés S; Pons V; Honorato P; Martinez LO; Lamperti L; Aguayo C; Radojkovic C Microvasc Res; 2015 Mar; 98():9-15. PubMed ID: 25445031 [TBL] [Abstract][Full Text] [Related]
12. Cell surface adenylate kinase activity regulates the F(1)-ATPase/P2Y (13)-mediated HDL endocytosis pathway on human hepatocytes. Fabre AC; Vantourout P; Champagne E; Tercé F; Rolland C; Perret B; Collet X; Barbaras R; Martinez LO Cell Mol Life Sci; 2006 Dec; 63(23):2829-37. PubMed ID: 17103109 [TBL] [Abstract][Full Text] [Related]
13. Ecto-F₁-ATPase: a moonlighting protein complex and an unexpected apoA-I receptor. Vantourout P; Radojkovic C; Lichtenstein L; Pons V; Champagne E; Martinez LO World J Gastroenterol; 2010 Dec; 16(47):5925-35. PubMed ID: 21157968 [TBL] [Abstract][Full Text] [Related]
14. Ectopic beta-chain of ATP synthase is an apolipoprotein A-I receptor in hepatic HDL endocytosis. Martinez LO; Jacquet S; Esteve JP; Rolland C; Cabezón E; Champagne E; Pineau T; Georgeaud V; Walker JE; Tercé F; Collet X; Perret B; Barbaras R Nature; 2003 Jan; 421(6918):75-9. PubMed ID: 12511957 [TBL] [Abstract][Full Text] [Related]
15. Kinetic analysis of the inhibition mechanism of bovine mitochondrial F1-ATPase inhibitory protein using biochemical assay. Kobayashi R; Mori S; Ueno H; Noji H J Biochem; 2021 Sep; 170(1):79-87. PubMed ID: 33693769 [TBL] [Abstract][Full Text] [Related]
16. Up-regulation of the ATPase inhibitory factor 1 (IF1) of the mitochondrial H+-ATP synthase in human tumors mediates the metabolic shift of cancer cells to a Warburg phenotype. Sánchez-Cenizo L; Formentini L; Aldea M; Ortega AD; García-Huerta P; Sánchez-Aragó M; Cuezva JM J Biol Chem; 2010 Aug; 285(33):25308-13. PubMed ID: 20538613 [TBL] [Abstract][Full Text] [Related]
17. Insight into the bind-lock mechanism of the yeast mitochondrial ATP synthase inhibitory peptide. Corvest V; Sigalat C; Haraux F Biochemistry; 2007 Jul; 46(29):8680-8. PubMed ID: 17595113 [TBL] [Abstract][Full Text] [Related]
18. Docking the mitochondrial inhibitor protein IF1 to a membrane receptor different from the F1-ATPase beta subunit. Lopez-Mediavilla C; Vigny H; Godinot C Eur J Biochem; 1993 Jul; 215(2):487-96. PubMed ID: 8344316 [TBL] [Abstract][Full Text] [Related]
19. A reference measurement of circulating ATPase inhibitory factor 1 (IF1) in humans by LC-MS/MS: Comparison with conventional ELISA. Genoux A; Duparc T; Ruidavets JB; Ingueneau C; Najib S; Ferrières J; Perret B; Croyal M; Martinez LO Talanta; 2020 Nov; 219():121300. PubMed ID: 32887042 [TBL] [Abstract][Full Text] [Related]
20. The ATPase Inhibitory Factor 1 (IF1): A master regulator of energy metabolism and of cell survival. García-Bermúdez J; Cuezva JM Biochim Biophys Acta; 2016 Aug; 1857(8):1167-1182. PubMed ID: 26876430 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]